Login
  • Home
  • Medicines
  • Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion

Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion

*
Pharmacy Only: Prescription

  • Company:

    GlaxoSmithKline (Ireland) Ltd

  • Status:

    Updated

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Belimumab

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

qrcode image

Scan the QR code or enter an email to access and share this medicine:

Summary of Product Characteristics last updated on medicines.ie: 24/7/2025 Download PDF

GlaxoSmithKline (Ireland) Ltd

GlaxoSmithKline (Ireland) Ltd

  • Address:

    12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

  • Telephone:

    +353 1 495 5000

  • Medical Information Direct Line:

    1 800 244 255